Humacyte, Inc. - HUMA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Jul 13, 2026 | SCHEDULE 13D/A | — | 5.0% | — | View |
| Jun 22, 2026 | SCHEDULE 13G | M.H. Davidson & Co. | 0.09% | 232,724 | View |
| Jun 22, 2026 | SCHEDULE 13G | Davidson Kempner Arbitrage, Equities & Relative Value LP | 4.66% | 12,554,349 | View |
| Jun 22, 2026 | SCHEDULE 13G | Davidson Kempner Capital Management LP | 4.74% | 12,787,073 | View |
| Jun 22, 2026 | SCHEDULE 13G | Anthony A. Yoseloff | 4.74% | 12,787,073 | View |
| Jun 15, 2026 | SCHEDULE 13D/A | — | 8.4% | — | View |
| Apr 27, 2026 | SCHEDULE 13D/A | — | — | — | View |
| Mar 24, 2026 | SCHEDULE 13D/A | — | 9.5% | — | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.